Announcements

LCID Researcher's Work to Translate Science Featured on UNESCO Website

Dr. Grace Kago's science e-learning community for native Kikuyu speakers is chosen for UNESCO's Open and Inclusive Science Hub.

Grace Kago, Ph.D.

Newsletter

Julie Gerberding Discusses Precision Health at 2025 LaMontagne Symposium Keynote Lecture

The title of Dr. Gerberding's lecture was "Beyond One-Size-Fits-All: Rebuilding Trust and Advancing Precision Public Health in the AI Era"

Julie Gerberding speaking at 2025 LaMontagne Symposium

Accolades

Three UT Austin Faculty Members Selected to the American Association for the Advancement of Science

Ken Keiler studies basic molecular biology with the aim of developing new antibiotics.

Research

Research Identifies Key Antibodies for Development of Broadly Protective Norovirus Vaccine

Discovery brings us one step closer to vaccine and treatment for prevalent virus.

Announcements

UT Vaccine Scientist Will Be Inducted Into National Inventors Hall of Fame

McLellan, who will be inducted in Washington, D.C. on May 8, is among the youngest new inductees in hall of fame history.

Newsletter

John F. Brooks II Presents 2024 Richard J. Meyer Lecture

Dr. Brooks’ lecture explored his research into the connection between the circadian clock and immune function in the gut microbiome of mice.

Dr. John F. Brooks II, Assistant Professor of Molecular Biology at Princeton University, will present the 2024 Richard J. Meyer Lecture.

Features

Preparing for Future Outbreaks, Experts Use Disease Simulation Exercise

Public health officials and researchers gathered this month for a gamified version of an outbreak investigation.

Research

Newly Discovered Antimicrobial Could Prevent or Treat Cholera

Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.

UT News

Newly Discovered Antibody Protects Against All COVID-19 Variants

Researchers have discovered an antibody able to neutralize all known variants of SARS-CoV-2, the virus that causes COVID-19, as well as similar coronaviruses.

Research

AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria

Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.